Terahertz waves facilitate capsaicin expulsion from TRPV1

Z Zhi Zhu (State Key Laboratory of Physical Chemistry of Solid Surfaces, Key Laboratory for Chemical Biology of Fujian Province, The MOE Key Laboratory of Spectrochemical Analysis and Instrumentation, Department of Chemical Biology, College of Chemistry and Chemical Engineering, State Key Laboratory of Vaccines for Infectious Diseases, Fujian Provincial Key Laboratory of Innovative Drug Target Research, School of Pharmaceutical Sciences, School of Life Sciences, Faculty of Medicine and Life Sciences) J Junquan Zhu S Shiyu Gu (School of Optical-Electrical and Computer Engineering, University of Shanghai for Science and Technology 1 , Shanghai 200093,) A Anqi Wang P Peng Chen J Jihua Cao (The First College of Clinical Medical Science, China Three Gorges University 3 , Yichang 443002,) Y Yangmei Li

Abstract

Transient receptor potential vanilloid 1 (TRPV1) is a critical non-selective cation channel involved in various biological and physiological processes, making it a promising drug target for treating multiple diseases. Capsaicin, a TRPV1 agonist, is widely used to relieve pain by desensitizing the TRPV1 with persistent stimulation. However, the initially intolerable burning sensation due to TRPV1 activation necessitates the use of antagonists to deactivate TRPV1 and mitigate discomfort, which yet causes thermoregulation disorders. In this study, molecular dynamics simulations reveal that frequency-specific terahertz (THz) waves can promote capsaicin unbinding from TRPV1, suggesting a spatiotemporally controlled approach for TRPV1 deactivation. The THz wave resonates with the hydroxyl group in the capsaicin head, increasing its rotational kinetic energy and promoting its rotation. This disrupts the key hydrogen bond between the hydroxyl group and TRPV1 residue E570, significantly reducing capsaicin’s affinity for TRPV1. Our findings suggest that THz waves could mimic TRPV1 antagonists in a more flexible way, offering temporal control over capsaicin recruitment and expulsion (i.e., TRPV1 activation, desensitization, and deactivation) for more comfortable pain relief. In addition, this work enlightens a THz-based, pill-free strategy to control the pain induced by inflammatory ligands activated TRPV1.

Article Details

Volume / Issue Vol. 162, Issue 18
Published May 14, 2025
ISSN 0021-9606
Publisher American Institute of Physics

Journal Info

The Journal of Chemical Physics

American Institute of Physics

ISSN: 0021-9606 Physical Sciences

Authors (7)

Z

Zhi Zhu

State Key Laboratory of Physical Chemistry of Solid Surfaces, Key Laboratory for Chemical Biology of Fujian Province, The MOE Key Laboratory of Spectrochemical Analysis and Instrumentation, Department of Chemical Biology, College of Chemistry and Chemical Engineering, State Key Laboratory of Vaccines for Infectious Diseases, Fujian Provincial Key Laboratory of Innovative Drug Target Research, School of Pharmaceutical Sciences, School of Life Sciences, Faculty of Medicine and Life Sciences

J

Junquan Zhu

S

Shiyu Gu

School of Optical-Electrical and Computer Engineering, University of Shanghai for Science and Technology 1 , Shanghai 200093,

A

Anqi Wang

P

Peng Chen

J

Jihua Cao

The First College of Clinical Medical Science, China Three Gorges University 3 , Yichang 443002,

Y

Yangmei Li